Nintedanib Impurity 55 | CAS 1139453-98-7 - Request Quote
Nintedanib Impurity 55
| SZ CAT No: | SZ-N023077 |
| CAS No | 1139453-98-7 |
| Mol.F. | C14H20N4O3 |
| Mol.Wt. | 292.3 |
| Inv. Status | In Stock |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Nintedanib Impurity 55 is chemically N-Methyl-2-(4-methylpiperazin-1-yl)-N-(4-nitrophenyl)acetamide. Nintedanib Impurity 55 is supplied with detailed characterization data compliant with regulatory guideline. Nintedanib Impurity 55 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nintedanib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1139453-98-7
Purchase 1139453-98-7
Order 1139453-98-7
Enquire 1139453-98-7
price of 1139453-98-7
1139453-98-7 Supplier
1139453-98-7 Manufacturer
1139453-98-7 Exporter
buy high quality Nintedanib Impurity 55
Purchase Nintedanib Impurity 55
Nintedanib Impurity 55 suppliers
Nintedanib Impurity 55 manufacturers
Nintedanib Impurity 55 price
Order Nintedanib Impurity 55
Enquire Nintedanib Impurity 55
Nintedanib Impurity 55 cost
Nintedanib Impurity 55 Supplier
Nintedanib Impurity 55 Distributor
Nintedanib Impurity 55 for Method Validation
Nintedanib Reference Standard
Nintedanib Impurity 55 for ANDA Filing
Nintedanib Impurity 55 for Forced Degradation Studies
Nintedanib Impurity 55 Identification Standards
Nintedanib Impurity 55 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.